BMS dans l'actualité
Création d'environnements éco-sains
Tamtam a trouvé 20 articles récents sur BMS.
- Novartis, BMS Pause Autoimmune CAR-T Trials After Safety Events
- BMS ends Cellares pact over cell therapy production problems, triggering layoffs
- News by ACCESS Newswire on TradingView, 2026-08-25
- BMS Deploys NVIDIA DGX Vera Rubin Systems to Accelerate AI-Powered R&D
- ‘Farm machinery mechanics taught me about people as well as engineering’
- Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
- Soft market opens buyer’s window for marine insurance, but act fast: BMS
- BMS opens Mumbai capability centre
- BMS expands AI and analytics footprint in India
- BMS CAT Case Study
- BMS launches delegated authority and consortia team
- 1,031,666,700 Ordinary Shares of BMS Holdings Berhad are subject to a Lock-Up Agreement Ending on 8-JUN-2026.
- BMS-Hengrui deal strikes panic in Washington
- Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
- Texas comptroller recommends Bristol Myers Squibb's $1B manufacturing plant for tax break
- BMS-Hengrui deal strikes panic in Washington
- GOP chairman of China panel seeks biotech clampdown, calls out BMS deal
- Bristol Myers Squibb Eyeing Generation Park for Manufacturing Plant
- Tempus AI And BMS Deepen AI Drug Development Ties As Losses Persist
- Tempus broadens collaboration with BMS for clinical trials
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme BMS ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires